Citigroup’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-88,675
| Closed | -$914K | – | 5948 |
|
|
2023
Q3 | $914K | Sell |
88,675
-88
| -0.1% | -$835 | ﹤0.01% | 2595 |
|
|
2023
Q2 | $732K | Sell |
88,763
-3,640
| -4% | -$21.8K | ﹤0.01% | 3076 |
|
|
2023
Q1 | $517K | Sell |
92,403
-15,200
| -14% | -$87K | ﹤0.01% | 3110 |
|
|
2022
Q4 | $533K | Hold |
107,603
| – | – | ﹤0.01% | 3121 |
|
|
2022
Q3 | $516K | Sell |
107,603
-227
| -0.2% | -$973 | ﹤0.01% | 3212 |
|
|
2022
Q2 | $277K | Sell |
107,830
-49,070
| -31% | -$184K | ﹤0.01% | 3651 |
|
|
2022
Q1 | $904K | Sell |
156,900
-157,058
| -50% | -$1.41M | ﹤0.01% | 3066 |
|
|
2021
Q4 | $4.71M | Buy |
313,958
+23,598
| +8% | +$430K | ﹤0.01% | 1881 |
|
|
2021
Q3 | $7.61M | Buy |
290,360
+4,060
| +1% | +$150K | ﹤0.01% | 1556 |
|
|
2021
Q2 | $14.3M | Sell |
286,300
-42,617
| -13% | -$1.91M | 0.01% | 1202 |
|
|
2021
Q1 | $15.1M | Buy |
328,917
+3,457
| +1% | +$165K | 0.01% | 1108 |
|
|
2020
Q4 | $13.9M | Buy |
325,460
+23,740
| +8% | +$901K | 0.01% | 1293 |
|
|
2020
Q3 | $12.3M | Buy |
301,720
+1,659
| +0.6% | +$82.6K | 0.01% | 1213 |
|
|
2020
Q2 | $16.4M | Buy |
300,061
+24,431
| +9% | +$1.4M | 0.01% | 948 |
|
|
2020
Q1 | $14.4M | Sell |
275,630
-43,196
| -14% | -$2.34M | 0.01% | 929 |
|
|
2019
Q4 | $15.5M | Buy |
318,826
+3,516
| +1% | +$165K | 0.01% | 1128 |
|
|
2019
Q3 | $17.3M | Buy |
315,310
+1,773
| +0.6% | +$101K | 0.01% | 1005 |
|
|
2019
Q2 | $15.7M | Buy |
313,537
+3,949
| +1% | +$197K | 0.01% | 1084 |
|
|
2019
Q1 | $17.5M | Buy |
309,588
+296,885
| +2,337% | +$17.7M | 0.02% | 911 |
|
|
2018
Q4 | $810K | Buy |
12,703
+813
| +7% | +$57.6K | ﹤0.01% | 3614 |
|
|
2018
Q3 | $966K | Buy |
11,890
+9,080
| +323% | +$665K | ﹤0.01% | 3540 |
|
|
2018
Q2 | $180K | Buy |
2,810
+1,067
| +61% | +$52.3K | ﹤0.01% | 5175 |
|
|
2018
Q1 | $68K | Buy |
1,743
+769
| +79% | +$26.9K | ﹤0.01% | 5946 |
|
|
2017
Q4 | $27K | Buy |
+974
| New | +$28.5K | ﹤0.01% | 6576 |
|
|
2017
Q3 | – | Sell |
-62
| Closed | -$1K | – | 7506 |
|
|
2017
Q2 | $1K | Sell |
62
-77
| -55% | -$1.04K | ﹤0.01% | 7236 |
|
|
2017
Q1 | $2K | Sell |
139
-4,901
| -97% | -$70.4K | ﹤0.01% | 7023 |
|
|
2016
Q4 | $75K | Buy |
+5,040
| New | +$64.5K | ﹤0.01% | 5949 |
|
Other funds holding TRHC
Citigroup's TRHC Position: Q4 2023 in Review
Citigroup sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 88,675 shares — an estimated $914K sold.
Citigroup first reported a position in TRHC in Q4 2016 and held it in 27 quarters. The position peaked at $17.5M in Q1 2019. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Citigroup reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citigroup sold 88,675 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $914K.
- Citigroup first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 27 quarters.
- Citigroup's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $17.5M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Citigroup's 13F filing for Q4 2023, filed 9 Feb 2024.